2cureX AB (publ) 9,21
2cureX AB (publ) operates as a medtech company in Europe. Its principal product is IndiTreat, an IVD test, which helps to predict cancer patient's response and resistance to different drugs and select the appropriate treatment. The company is also conducting various clinical programs for IndiTreat for breast colorectal, ovarian, and pancreatic cancers. 2cureX AB (publ) was incorporated in 2006 and is based in Copenhagen, Denmark. Læs mere
Kr. 162M Markedsværdi (Mcap)
Kr. 4,0M Omsætning
Bioteknologi Industri
Sverige Handles på børsen
2curex.com Hjemmeside
Sundhed Sektor